Does GLOFITAMAB Cause Thrombocytopenia? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Thrombocytopenia have been filed in association with GLOFITAMAB (Columvi). This represents 2.2% of all adverse event reports for GLOFITAMAB.
24
Reports of Thrombocytopenia with GLOFITAMAB
2.2%
of all GLOFITAMAB reports
4
Deaths
10
Hospitalizations
How Dangerous Is Thrombocytopenia From GLOFITAMAB?
Of the 24 reports, 4 (16.7%) resulted in death, 10 (41.7%) required hospitalization, and 2 (8.3%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for GLOFITAMAB.
What Other Side Effects Does GLOFITAMAB Cause?
Cytokine release syndrome (415)
Disease progression (183)
Off label use (129)
Death (125)
Neutropenia (109)
Pyrexia (78)
Febrile neutropenia (69)
Covid-19 (62)
Drug ineffective (53)
Immune effector cell-associated neurotoxicity syndrome (45)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which GLOFITAMAB Alternatives Have Lower Thrombocytopenia Risk?
GLOFITAMAB vs GLOFITAMAB-GXBM
GLOFITAMAB vs GLUCAGON
GLOFITAMAB vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB vs GLUCARPIDASE
GLOFITAMAB vs GLUCOPHAGE